Sandra Milligan
President presso ASPIRA WOMEN'S HEALTH INC.
Patrimonio netto: 575 421 $ in data 31/03/2024
Profilo
Sandra Milligan è un direttore indipendente di Gossamer Bio, Inc. e un responsabile della ricerca e dello sviluppo di Organon & Co. Fa parte del Consiglio di amministrazione di Gossamer Bio, Inc. La sig.ra Milligan è stata precedentemente impiegata come vicepresidente degli affari normativi presso Genentech, Inc. Ha conseguito la laurea presso l'Università della California, Irvine, una laurea presso il Georgetown University Law Center e un dottorato presso la George Washington University School of Medicine & Health.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ORGANON & CO.
0.01% | 04/05/2023 | 28 599 ( 0.01% ) | 537 661 $ | 31/03/2024 |
GOSSAMER BIO, INC.
0.01% | 15/11/2023 | 32 000 ( 0.01% ) | 37 760 $ | 31/03/2024 |
Posizioni attive di Sandra Milligan
| Società | Posizione | Inizio |
|---|---|---|
| GOSSAMER BIO, INC. | Director/Board Member | 10/06/2021 |
| ASPIRA WOMEN'S HEALTH INC. | President | 01/04/2024 |
Precedenti posizioni note di Sandra Milligan
| Società | Posizione | Fine |
|---|---|---|
| ORGANON & CO. | Chief Tech/Sci/R&D Officer | 01/01/2024 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 01/04/2020 |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Director/Board Member | 01/01/2017 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2015 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2012 |
Formazione di Sandra Milligan
| University of California, Irvine | Undergraduate Degree |
| Georgetown University Law Center | Graduate Degree |
| George Washington University School of Medicine & Health | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| ASPIRA WOMEN'S HEALTH INC. | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| ORGANON & CO. | Health Technology |
| Aziende private | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Commercial Services |
| The United States Army Medical Service Corps |
- Borsa valori
- Insiders
- Sandra Milligan
